UP Ibalon Bicol: antibodies

Showing posts with label antibodies. Show all posts

H1N1 flu vaccination in US starts in October

9/14/2009 | Posted by mesiamd | Edit Post

With the onset of school, health experts fear that the spread of the swine flu will intensify. That’s why they plan to start the vaccination in about three weeks to protect as much individuals as possible to the pandemic virus.

Earlier, it was thought that the new H1N1 flu virus would need a two step dosing to achieve a level of immunity during the vaccination, but recent studies on patients with ages 18 to 64 years showed that a single dose containing 15 micrograms of the viral antigen was enough to stimulate protective levels of antibodies. From the initial results, the vaccine which didn’t contain adjuvant to boost its efficacy, showed no serious side-effects.

“The results of the vaccine studies suggest one dose of the formula used by drugmakers should offer H1N1 protection similar to the seasonal flu shot. Paris-based Sanofi Aventis SA, London- based GlaxoSmithKline Plc, and Basel, Switzerland-based Novartis AG are among the other companies making the vaccine. “---- Bloomberg.com (09/13/09, Randall, T; Gale, J.)

The single dose regimen will simplify the vaccination process and appreciably increase the production and stockpile of Paris-based Sanofi Aventis SA, London- based GlaxoSmithKline Plc, and Basel, Switzerland-based Novartis AG which are making the vaccines. There are plans in the US to donate prepared vaccines to poor countries. Since the experience their use is limited, more studies are needed to validate the initial findings to ascertain the efficacy and safety of the drug. (Photo Credit: CDC) =0=

==========================================================

Labels: antibodies, antiviral, H1N1 virus, Influenza, influenza virus, prevention, Swine flu, Totie Mesia, vaccination, vaccine

Seminar on Immunoglobulin-rich Milk (IgCo)

1/07/2009 | Posted by mesiamd | Edit Post

Dr. Amy Goleta-Dy of St. Luke’s Medical Center Pediatric Oncology Department announces a product presentation and information dissemination seminar on the varied uses of Ig-Co, the colostrum-based milk product developed in New Zealand. The nutritive bovine milk packed with disease-fighting immunoglobulins (antibodies) will be the central topic in conferences slated in the following dates and venues:

1. January 16, 2009, 5:30 p.m. at Villa Caceres, Magsaysay Avenue, Naga City
2. January 18, 2009, 2:00 p.m. at Casablanca Hotel, Penaranda, Legazpi City
3. January 24, 2009, 3:00 p.m. at Waterfront Hotel, Lahug, Cebu City

“The newly introduced product is helpful for a lot of medical conditions including those with diabetes, asthma, allergies, patients with disordered and depressed immunity (immunocompromised,) cancer patients on chemotherapy, and those with chronic kidney problems and osteoporosis.” Colostrum Conference in Bicol (10/28/08, mesiamd)

Open to the public (free,) the seminars are suggested for those who might benefit from taking IgCo and those who want to promote the product in their respective communities. For more information contact: Dr. Amy Goleta-Dy at 09178126135 or Agnes at 09175802301 (Photo Credit: Tambakothejaguar) =0=

=============================================================

Labels: antibodies, Colostrum, Dr. Amy Goleta-Dy, food, immunoglobulins, milk bank, nutrition

UP Ibalon Bicol

H1N1 flu vaccination in US starts in October

Seminar on Immunoglobulin-rich Milk (IgCo)

Blog Archive

About Me

UP Ibalon Newsmakers

Topics/Categories

Feedjit Live Blog Stats

Topics/Categories

Featured

Ateneo de Naga HS Batch 74

ABS-CBN News

Recent Posts

GMA News.tv

Philippine Commentary

Inquirer Breaking News